QR Code

Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use cases

Background: Personalized therapy approaches targeting homologous recombination deficiency (HRD) in biliary tract cancer (BTC) remain poorly explored with limited clinical data available. Beyond BRCA1/2, the therapeutic implications of BRCA1-associated protein 1 (BAP1) alterations are unclear. Materi...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: M. Barsch, I. Godbole, P. Metzger, M. Benzing, L. Klaas, A. Decker, A. Dammer, J. Weiß, E.-P. Dopfer, L. Gräßel, J. Kuehn, C. Miething, H. Becker, S. Lassmann, P. Bronsert, A.M. Schultheis, M. Werner, M. Boerries, J. Duyster, R. Thimme, M. Hofmann, M. Quante, B. Bengsch
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2026-06-01
Rangatū:ESMO Gastrointestinal Oncology
Ngā marau:
biliary tract cancer
precision oncology
molecular tumor board
imaging mass cytometry
tumor immune microenvironment
BAP1
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S294981982600018X
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite